DD202502A5 - Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit - Google Patents

Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit Download PDF

Info

Publication number
DD202502A5
DD202502A5 DD82241507A DD24150782A DD202502A5 DD 202502 A5 DD202502 A5 DD 202502A5 DD 82241507 A DD82241507 A DD 82241507A DD 24150782 A DD24150782 A DD 24150782A DD 202502 A5 DD202502 A5 DD 202502A5
Authority
DD
German Democratic Republic
Prior art keywords
granules
soluble
carbon atoms
gastric juice
capsule
Prior art date
Application number
DD82241507A
Other languages
German (de)
English (en)
Inventor
Klaus Gleixner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6136567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD202502(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DD202502A5 publication Critical patent/DD202502A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fishing Rods (AREA)
  • Materials For Photolithography (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
DD82241507A 1981-07-10 1982-07-08 Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit DD202502A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813127237 DE3127237A1 (de) 1981-07-10 1981-07-10 Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD202502A5 true DD202502A5 (de) 1983-09-21

Family

ID=6136567

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82241507A DD202502A5 (de) 1981-07-10 1982-07-08 Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit

Country Status (17)

Country Link
US (1) US4542011A (pt)
EP (1) EP0069958B2 (pt)
JP (1) JPS5818318A (pt)
KR (1) KR880000971B1 (pt)
AT (1) ATE18851T1 (pt)
AU (1) AU553925B2 (pt)
CA (1) CA1178204A (pt)
DD (1) DD202502A5 (pt)
DE (2) DE3127237A1 (pt)
DK (1) DK166758B1 (pt)
FI (1) FI81259C (pt)
HU (1) HU187774B (pt)
IE (1) IE53581B1 (pt)
IL (1) IL66282A (pt)
NO (1) NO157244C (pt)
PT (1) PT75217B (pt)
ZA (1) ZA824901B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3405378A1 (de) * 1984-02-15 1985-08-22 Röhm GmbH, 6100 Darmstadt Arzneimittelueberzug
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4874605A (en) * 1987-11-27 1989-10-17 Hoechst-Roussel Pharmaceuticals Inc. Stabilized delayed release emulsion
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
IN186245B (pt) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064230A (en) * 1966-04-25 1977-12-20 Schmid Laboratories, Inc. Polyenic macrolide compositions
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
BE725125A (pt) * 1967-12-16 1969-06-09
IL45337A (en) * 1973-08-10 1977-04-29 Saarstickstoff Fatol Gmbh Therapeutical composition containing an isonicotinic acid hydrazide thioisonicotinic acid amide sulfones and/or sulfonamides for the treatment of mycobacterioses
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
AR215459A1 (es) * 1976-04-02 1979-10-15 Brewer J Metodo para producir un agente terapeutico capaz de proporcionar una marca en un animal no humano para indicar la administracion del agente al animal y para proporcionar tambien un repositorio del agente a ser libeberado durante un espacio de tiempo
US4096252A (en) * 1976-06-10 1978-06-20 J. Uriach & Cia S.A. 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
JPS5611687A (en) * 1980-06-02 1981-02-05 Fujitsu Ltd Semiconductor memory unit

Also Published As

Publication number Publication date
DK166758B1 (da) 1993-07-12
NO157244B (no) 1987-11-09
AU8578082A (en) 1983-01-13
FI822441L (fi) 1983-01-11
FI81259B (fi) 1990-06-29
EP0069958B2 (de) 1991-03-27
IE53581B1 (en) 1988-12-21
AU553925B2 (en) 1986-07-31
HU187774B (en) 1986-02-28
EP0069958B1 (de) 1986-04-02
KR880000971B1 (ko) 1988-06-07
IL66282A (en) 1987-01-30
CA1178204A (en) 1984-11-20
PT75217B (de) 1985-01-07
DK310582A (da) 1983-01-11
EP0069958A3 (en) 1983-06-29
PT75217A (de) 1982-08-01
NO157244C (no) 1988-02-24
ATE18851T1 (de) 1986-04-15
EP0069958A2 (de) 1983-01-19
NO822399L (no) 1983-01-11
DE3270241D1 (en) 1986-05-07
FI81259C (fi) 1990-10-10
IE821661L (en) 1983-01-10
DE3127237A1 (de) 1983-01-20
FI822441A0 (fi) 1982-07-08
US4542011A (en) 1985-09-17
KR840000238A (ko) 1984-02-18
JPS5818318A (ja) 1983-02-02
ZA824901B (en) 1983-04-27
IL66282A0 (en) 1982-11-30
JPH0419969B2 (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
CA2947528C (en) Extended release suspension compositions
DE69631834T2 (de) Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
EP1117387B1 (de) Überzogene arzneiformen mit kontrollierter wirkstoffabgabe
DE2336218C3 (de) Orale Arzneiform
DE2651176C2 (pt)
DE60103186T2 (de) Stossweise freisetzende Arzneiabgabesysteme
FI97686C (fi) Menetelmä helmien valmistamiseksi tarkoituksena tuottaa hallitusti vapauttavia tuotteita
DE69429826T3 (de) Opioid-formulierungen zur schmerzbehandlung
EP0551820B1 (de) Geschmacksmaskierte pharmazeutische Mittel
EP0261181B1 (de) Nifedipinkombinationspräparat
DE60208673T2 (de) Umhüllte pellets auf basis eines ace-hemmers
DE60010464T2 (de) Geschmackskaschierte flüssige arzneizubereitungen
EP0368216B1 (de) Feste pharmazeutische Retardform
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
DD202502A5 (de) Verfahren zur herstellung einer arzneiform mit verbesserter magenvertraeglichkeit
DE3915150A1 (de) Lang-wirkende diclofenac-natrium-praeparation
EP0387782A3 (de) Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung
EP1315481B1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE2741755A1 (de) Ueberzugsmassen auf polymerbasis fuer biologisch aktive praeparate und verfahren zur herstellung der ersteren sowie biologisch aktive praeparate und verfahren zur herstellung der letzteren
EP0208144B1 (de) Ambroxol oder bromhexin enthaltendes arzneimittelgranulat
DE202021100040U1 (de) Ethylcellulose-beschichtete Partikel enthaltend ein Salz aus Tapentadol und Phosphorsäure
DE1467919C (de) Verwendung des Aluminiumsalzes der O-Acetylsalicylsäure in festen Arzneizubereitungsformen mit Depot-Wirkung
DE1175826B (de) Verfahren zur Herstellung von Arzneipraeparaten zur oralen Verabreichung
DE1492081A1 (de) Verfahren zur Herstellung von leicht einnehmbaren Presstabletten
DE19928312A1 (de) Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee